Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus

Journal of Viral Hepatitis

Volumn 17, Issue 1, 2010, Pages 65-76

  Boyd, A ^a   Lacombe, K ^a,b   Miailhes, P ^c   Gozlan, J ^b,d   Bonnard, P ^e   Molina, J M ^b   Lascoux Combe, C ^f   Serfaty, L ^b   Gault, E ^g,h   Desvarieux, M ^a,i   Girard, P M ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔTEL DIEU   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e HÔPITAL TENON   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g AVICENNE HOSPITAL   (France)

^h UNIVERSITÉ PARIS 13   (France)

ⁱ NONE   (United States)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatitis D virus; Human immunodeficiency virus; Viral replication

Indexed keywords

LAMIVUDINE; TENOFOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COMORBIDITY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS D; HEPATITIS DELTA VIRUS; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA;

EID: 72949123526     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01153.x     Document Type: Article

References (45)

1. Arribas JR, Gonzalez-Garcia JJ, Lorenzo A et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS 2005 19 (13 1361 1365.
2. Konopnicki D, Mocroft A, de Wit S et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005 19 (6 593 601.
3. Rockstroh JK, Mocroft A, Soriano V et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005 192 (6 992 1002. (Pubitemid 41266795)
4. Gaeta GB, Precone DF, Cozzi-Lepri A, Cicconi P, D'Arminio Monforte A. Multiple viral infections. J Hepatol 2006 44 (Suppl. 1 S108 S113.
5. Lacombe K, Boyd A, Desvarieux M et al. Impact of chronic hepatitis C andor D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus. AIDS 2007 21 (18 2546 2549.
6. Sheng WH, Hung CC, Kao JH et al. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis 2007 44 (7 988 995.
7. Buti M, Jardi R, Allende H et al. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J Med Virol 1996 49 (1 66 69.
8. Govindarajan S, Cassidy WM, Valinluck B, Redeker AG. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection. Prog Clin Biol Res 1991 364 : 207 210.
9. Pol S, Wesenfelder L, Dubois F et al. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers. J Viral Hepat 1994 1 (2 131 137.
10. Puoti M, Rossi S, Forleo MA et al. Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection. J Hepatol 1998 29 (1 45 52.
11. Raimondo G, Brunetto MR, Pontisso P et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virushepatitis C virus-coinfected patients. Hepatology 2006 43 (1 100 107.
12. Filippini P, Coppola N, Pisapia R et al. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. J Med Virol 2007 79 (11 1679 1685.
13. Lacombe K, Massari V, Girard PM et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS 2006 20 (3 419 427.
14. Murphy DG, Cote L, Fauvel M, Rene P, Vincelette J. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2000 38 (11 4034 4041.
15. Allice T, Cerutti F, Pittaluga F et al. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 2007 45 (3 828 834.
16. Gorrin G, Friesenhahn M, Lin P et al. Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification. J Clin Microbiol 2003 41 (1 310 317. (Pubitemid 36098593)
17. Schutten M, Peters D, Back NK et al. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2007 45 (6 1712 1717.
18. Le GalF, Gordien E, Affolabi D et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005 43 (5 2363 2369.
19. Radjef N, Gordien E, Ivaniushina V et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004 78 (5 2537 2544.
20. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986 42 (1 121 130.
21. Jardi R, Rodriguez F, Buti M et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001 34 (2 404 410.
22. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995 22 (4 Pt 1 1101 1108.
23. Liaw YF, Chien RN, Chen TJ, Sheen IS, Chu CM. Concurrent hepatitis C virus and hepatitis delta virus superinfection in patients with chronic hepatitis B virus infection. J Med Virol 1992 37 (4 294 297.
24. Liaw YF, Tsai SL, Sheen IS et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 1998 93 (3 354 359.
25. Mathurin P, Thibault V, Kadidja K et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000 7 (1 15 22.
26. Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000 32 (5 1106 1110.
27. Soriano V, Barreiro P, Martin-Carbonero L et al. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis. J Infect Dis 2007 195 (8 1181 1183. (Pubitemid 46543450)
28. Zarski JP, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998 28 (1 27 33.
29. Wu JC, Chen PJ, Kuo MY, Lee SD, Chen DS, Ting LP. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991 65 (3 1099 1104.
30. Deterding K, Pothakamuri SV, Schlaphoff V et al. Clearance of Chronic HCV Infection During Acute Delta Hepatitis. Infection 2007: doi: 10.1007/s150100077204-7.
31. Guo JT, Bichko VV, Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J Virol 2001; 75(18): 8516-8523.
32. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 (10 1395 1406.
33. Pugnale P, Pazienza V, Guilloux K, Negro F. Hepatitis delta virus inhibits alpha interferon signaling. Hepatology 2009 49 (2 398 406.
34. Lee J, Wu CC, Lee KJ et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A 2006 103 (6 1828 1833.
35. Monno L, Angarano G, Santantonio T et al. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV. J Med Virol 1991 34 (3 199 205.
36. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995 40 (7 1583 1588.
37. Maida I, Rios MJ, Perez-Saleme L et al. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses 2008 24 (5 679 683.
38. Benhamou Y, Thibault V, Vig P et al. Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1. J Hepatol 2006 44 (1 62 67.
39. Lacombe K, Gozlan J, Boelle PY et al. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. AIDS 2005 19 (9 907 915.
40. Di Martino V, Thevenot T, Colin JF et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002 123 (6 1812 1822. (Pubitemid 35408305)
41. Carrat F, Bani-Sadr F, Pol S et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004 292 (23 2839 2848.
42. Torriani FJ, Rodriguez-Torres M, Rockstroh JK et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004 351 (5 438 450.
43. Chung RT, Andersen J, Volberding P et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004 351 (5 451 459.
44. Sheldon J, Ramos B, Toro C et al. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Antivir Ther 2008 13 (1 97 102.
45. Lacombe K, Gozlan J, Boyd A et al. Hepatitis B Virus Blippers and Rebounders under Treatment with Tenofovir in HIV-Hepatitis B Virus Co-infection 16th Conference on Retroviruses and Opportunistic Infections. Montréal, Canada, 2009.